Rezera Inc.
PrivateLast Round
IPO
Oct 21, 2026
Est. Valuation
$136.5M
Total Funding Raised
$135M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Rezera Inc. operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Debt round in July 2026.
Rezera Inc. is a biotechnology company that develops oral small-molecule inhibitors of the NLRP3 inflammasome to treat inflammatory drivers of cardiovascular and neurologic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rezera Inc. Comparables
Compare Rezera Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Olatec Therapeutics | 86% | |
| Halia Therapeutics | 85% | |
| Ventus Therapeutics | 83% |
For institutional investors. Book with your work email.
Rezera Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Oct 21, 2026 | ||||
| Debt | Jul 17, 2026 | ||||
| Series C | Sep 20, 2022 | ||||
| Series B | Jun 3, 2020 | ||||
| Series A | Jun 25, 2018 | ||||
Seed | Jul 1, 2016 |
For institutional investors. Book with your work email.
Rezera Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Epidarex Capital | Series C, Series B, Series A, Seed |
| 5AM Ventures | Series C, Series B, Series A |
| Novo Ventures | Series B |
| F-Prime Capital | Series C, Series B, Series A |
| Sanofi Ventures | Series C, Series B |
| Sofinnova Partners | Series C, Series B, Series A |
| Novo Ventures | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 21, 2026
$100M raised in IPO round.
- Jul 17, 2026
$15M raised with Silicon Valley Bank.
For institutional investors. Book with your work email.
Rezera Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rezera Inc.'s valuation, stock price, and market status.
Is Rezera Inc. a public or private company?
Rezera Inc. is a private company.
What is the current stock price of Rezera Inc.?
Rezera Inc. is a private company, so its shares have no public market price. Caplight tracks Rezera Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rezera Inc. worth (valuation)?
Rezera Inc.'s valuation is estimated at $136.5M based on funding round data.
Can I buy Rezera Inc. stock?
Rezera Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rezera Inc.'s last funding round?
Rezera Inc.'s most recent funding round was IPO on October 21, 2026.
Who are the main investors in Rezera Inc.?
Key investors in Rezera Inc. include Epidarex Capital, 5AM Ventures, Novo Ventures, Sofinnova Partners.
Will Rezera Inc. IPO soon?
No public IPO plans have been announced for Rezera Inc..
How can I track Rezera Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Rezera Inc.'s shares on secondary markets.